Targeting cancer metabolic vulnerabilities for advanced therapeutic efficacy - 29/04/23
Abstract |
Cancer metabolism is how cancer cells utilize nutrients and energy to support their growth and proliferation. Unlike normal cells, cancer cells have a unique metabolic profile that allows them to generate energy and the building blocks they need for rapid growth and division. This metabolic profile is marked by an increased reliance on glucose and glutamine as energy sources and changes in how cancer cells use and make key metabolic intermediates like ATP, NADH, and NADPH. This script analyzes a comprehensive overview of the latest advances in tumor metabolism, identifying the key unresolved issues, elaborates on how tumor cells differ from normal cells in their metabolism of nutrients, and explains how tumor cells conflate growth signals and nutrients to proliferate. The metabolic interaction of tumorigenesis and lipid metabolism within the tumor microenvironment and the role of ROS as an anti-tumor agent by mediating various signaling pathways for clinical cancer therapeutic targeting are outlined. Cancer metabolism is highly dynamic and heterogeneous; thus, advanced technologies to better investigate metabolism at the unicellular level without altering tumor tissue are necessary for better research and clinical transformation. The study of cancer metabolism is an area of active research, as scientists seek to understand the underlying metabolic changes that drive cancer growth and to identify potential therapeutic targets.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Metabolic reprogramming is one of the inherent cancer hallmarks, enhanced by different metabolic signaling pathways in cancer. |
• | Metabolic transformation in cancer is essential for initiation, proliferation, progression, and survival. |
• | Cancer cells adapt to the tumor microenvironment and metabolize most of their glucose using biochemical pathways that do not require oxygen. |
Keywords : Cancer metabolism, Metabolic reprogramming and Pathways, Lipid metabolism, Reactive oxygen species, Tumor microenvironment
Plan
Vol 162
Article 114658- juin 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?